Introduction
============

Intracranial arteriovenous (AV) fistulas are rare cerebrovascular malformations, with less than 100 reported cases since 1970.^[@B1]^ According to a series reported by Halbach et al., AV fistulas account for 1.6% of all intracranial vascular malformations.^[@B2]^ Although the pathophysiological cause of pial AV fistulas remains unclear, they usually develop in childhood and are often associated with Rendu-Osler-Weber disease,^[@B3]^ Klippel-Trenaunay-Weber disease,^[@B4]^ Ehlers--Danlos syndrome,^[@B5]^ or neurofibromatosis type I,^[@B6]^ suggesting the importance of genetic abnormality.^[@B7]^ On the other hand, pial AV fistulas have also accompanied with cerebral vein thrombosis,^[@B8]^ and abnormal angiogenesis in cerebral ischemia, head trauma, or iatrogenic complications.^[@B5],[@B9],[@B10]^

Here, we describe a case which developed intracranial pial AV fistula supposed to be caused by dural tenting during prior surgery.

Case Report
===========

A 63-year-old woman was admitted to our institute to undergo an asymptomatic unruptured cerebral aneurysm. Cerebral angiography showed a right middle cerebral artery (MCA) aneurysm, but no other vascular anomalies ([Fig. 1A, B](#F1){ref-type="fig"}). A right pterional craniotomy was performed to clip the aneurysm. The aneurysm was occluded using two curved clips. Her postoperative course was uneventful and postoperative computed tomography (CT) showed no abnormal lesion. Cerebral angiography performed two weeks after the surgery revealed a vascular anomaly fed by the right MCA and drained through the Sylvian vein into the vein of Trolard ([Fig. 1C, D](#F1){ref-type="fig"}). We diagnosed as *de novo* pial AV fistula, and the disconnection of the fistula was performed to prevent hemorrhage from the lesion. Craniotomy was extended to cover the AV fistula. The dura matter over the lesion was dark reddish in color ([Fig. 2A](#F2){ref-type="fig"}). The dura was slightly adhered to the arachnoid membrane around the fistulous point ([Fig. 2B](#F2){ref-type="fig"}). The lesion was located dural tenting of the previous surgery ([Fig. 1E](#F1){ref-type="fig"}). After dural opening, the fistulous point and red vein was exposed ([Fig. 2C](#F2){ref-type="fig"}). Fluorescein video angiography revealed early venous filling of the Sylvian vein ([Fig. 2D](#F2){ref-type="fig"}). The fistulous point was clipped and the obliteration was confirmed with fluorescein video angiography ([Fig. 2E, F](#F2){ref-type="fig"}). Postoperative CT showed no abnormality, and cerebral angiography revealed the occlusion of the fistula ([Fig. 1F](#F1){ref-type="fig"}). She was discharged two weeks after the second surgery without deficit.

Discussion
==========

Intracranial pial AV fistulas are rare cerebrovascular lesions composed of several arterial connections to a single venous channel without any intervening nidus or capillary bed.^[@B2],[@B11]^ They differ from brain AV malformations in that they lack a true nidus, and differ from dural AV fistulas in that they derive their arterial supply from pial or cortical arteries and are not located within the dura mater.^[@B11]^

In the present case, neuroradiological examination showed a vascular anomaly on the surface of the cortex fed by the right MCA and that drained into the vein of Trolard through the Sylvian vein. There was no nidus or shunts from the external carotid artery.

Although the pathophysiologic mechanisms underlying acquired pial AV fistulas also remain to be elucidated, development has previously been attributed to venous hypertension following vein thrombosis such as dural AV fistulas.^[@B8]^ In the present case, cerebral angiography did not identify occlusion of any cerebral cortical vein or venous sinus.

Acquired pial AV fistulas also have been reported as a result of cerebral ischemia, contusion,^[@B5]^ oxidized regenerated cellulose,^[@B9]^ or ventriculostomy.^[@B10]^ It is suggested that abnormal angiogenesis and associated vascular growth factors and cytokines caused by mechanical damage to vessels might play a role in the development of pial AV fistulas.^[@B11]^ Up to now, there have been no case report of a pial AV fistula caused by dural tenting. The lesion was located just beneath the dural tenting applied during the previous surgery. Bleeding was not obvious while dural tenting, but the vessel wall might be injured by needle. Although we usually pay attention not to have the needle penetrated into the dura matter, the direct injury of vessel wall might be associated with the development of pial AV fistula.

Conclusion
==========

This is the first reported case of a pial AV fistula caused by dural tenting. The formation of a fistula can occur from trauma to cortical arteries and veins at the pial entry site. Although rare, we should pay attention to this as the surgical complications.

![A, B: Preoperative cerebral angiography showed a right middle cerebral artery (MCA) aneurysm projecting laterally, but no other vascular anomalies. C, D: Postoperative cerebral angiography revealed an arteriovenous fistula (*black arrow*) fed by the right MCA and drained through the Sylvian vein into the vein of Trolard (*white arrows*). E: The fistulous point was located just beneath the dural tenting (*black arrow*). F: Postoperative cerebral angiography revealed no shunting (*black arrow*).](nmc-54-242-g1){#F1}

![A: The dura matter over the lesion was dark reddish in color (*black arrow*). B: The dura was slightly adhered to the arachnoid membrane around the fistulous point (*black arrow*). C: After dural opening, the fistulous point (*black arrow*) and red vein (*white arrow heads*) was exposed. D: Fluorescein video angiography revealed early venous filling of the Sylvian vein (*white arrow heads*). E: After the fistulous point was clipped, the red vein normalized (*white arrow heads*). F: Disappearance of early venous filling (*white arrow heads*) and disconnection of the shunting was confirmed with fluorescein video angiography.](nmc-54-242-g2){#F2}

[^1]: **Conflicts of Interest Disclosure**

    The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.
